MedPath

Effect of oral contraceptive with gonadotropin-releasing hormone (GnRH) agonist versus Estradiol Valerate on the pregnancy continuity after frozen embryo transfer in infertile wome

Phase 2
Conditions
Artificial fertilization.
Complications associated with artificial fertilization
Registration Number
IRCT20120215009014N342
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
128
Inclusion Criteria

Age of 18 to 40 years,
Infertile women candidate for the embryo transfer process,
Having more than 3 embryos for transfer,
Having a healthy uterine cavity,
Having constant embryo culture medium,
Having a constant embryo transfer environment,
Having constant fetal quality,
Having fixed embryology,

Exclusion Criteria

Being a smoker,
Idiopathic infertility,
Patients with donated oocytes,

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy continuity after embryo transfer. Timepoint: 12 weeks after the intervention. Method of measurement: With ultrasonography.
Secondary Outcome Measures
NameTimeMethod
Ectopic pregnancy. Timepoint: 12 weeks after the intervention. Method of measurement: With ultrasonography.;Polygamous pregnancy. Timepoint: 12 weeks after the intervention. Method of measurement: With ultrasonography.;Spontaneous abortion. Timepoint: 12 weeks after the intervention. Method of measurement: With ultrasonography.
© Copyright 2025. All Rights Reserved by MedPath